A Randomized, Double-Blind, Placebo-Controlled Trial of Omalizumab Combined with Oral Immunotherapy (OIT) in the Treatment of Cow's Milk Allergy (CMA): Safety of Dosing

2014 ◽  
Vol 133 (2) ◽  
pp. AB403 ◽  
Author(s):  
Jennifer S. Kim ◽  
Robert A. Wood ◽  
Robert Lindblad ◽  
Sally A. Noone ◽  
Melissa N. Paterakis ◽  
...  
Keyword(s):  
Controlled Trial ◽  
Oral Immunotherapy ◽  
Cow’S Milk Allergy ◽  
Cow’S Milk ◽  
Milk Allergy ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Cow's Milk ◽  
Cow's Milk Allergy

scholarly journals A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy

2008 ◽  
Vol 122 (6) ◽  
pp. 1154-1160 ◽  
Author(s):  
Justin M. Skripak ◽  
Scott D. Nash ◽  
Hannah Rowley ◽  
Nga H. Brereton ◽  
Susan Oh ◽  
...  
Keyword(s):  
Oral Immunotherapy ◽  
Cow’S Milk Allergy ◽  
Cow’S Milk ◽  
Controlled Study ◽  
Milk Allergy ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Cow's Milk ◽  
Cow's Milk Allergy

scholarly journals Oral immunotherapy combined with omalizumab for high–risk cow’s milk allergy: a randomized controlled trial

2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Masaya Takahashi ◽  
Kazuhiko Soejima ◽  
Shoichiro Taniuchi ◽  
Yasuko Hatano ◽  
Sohsaku Yamanouchi ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
High Risk ◽  
Controlled Trial ◽  
Oral Immunotherapy ◽  
Cow’S Milk Allergy ◽  
Cow’S Milk ◽  
Milk Allergy ◽  
Cow's Milk ◽  
Randomized Controlled ◽  
Cow's Milk Allergy
Sign in / Sign up

Export Citation Format

Share Document